StockNews.AI
TOMZ
StockNews.AI
57 days

TOMI Environmental Solutions Demonstrates SteraMist Efficacy in Combatting Honeybee Colony Collapse

1. TOMI's SteraMist proved effective against Deformed Wing Virus in honeybees. 2. Colony losses reported up to 60% this year, risking $600 million impact. 3. SteraMist positions TOMI as key to global food security through environmental biosecurity. 4. Honeybees contribute $20–30 billion annually to the U.S. agricultural economy. 5. Ongoing research seeks scalable solutions to combat honeybee colony collapse.

6m saved
Insight
Article

FAQ

Why Bullish?

TOMI's advancement in combating a major agricultural crisis enhances its market position, similar to other biotech firms that surged post product validation.

How important is it?

The article indicates TOMZ's potential for growth within an essential industry, highlighting new applications for its product that could lead to significant market penetration.

Why Long Term?

As awareness and adoption of SteraMist increase, TOMI may see sustained revenue growth, akin to companies benefiting from novel agricultural solutions over time.

Related Companies

APHACORNAGRO
FREDERICK, Md., June 23, 2025 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), a global company specializing in disinfection and decontamination solutions, today announced significant advancements in the fight against the devastating honeybee colony collapse. In a collaborative study published on June 2, 2025, by the U.S. Department of Agriculture (USDA), SteraMist® ionized hydrogen peroxide (iHP) was shown to significantly inactivate Deformed Wing Virus (DWV), a primary driver of colony loss, particularly DWV strains A and B. The paper, “Deformed wing virus of honeybees is inactivated by cold plasma ionized hydrogen peroxide,” highlights SteraMist’s unique ability to reduce overt viral infection in hive substrates, offering a practical and non-toxic approach to protecting bee populations. “Pollinators are essential to the strength and sustainability of our nation’s food supply,” said Acting ARS Administrator Joon Park. “USDA scientists are actively advancing research into the major stressors affecting honeybee colonies, including new strategies to combat parasitic mites like Varroa, which remain a significant challenge to agricultural health. TOMI’s SteraMist technology has demonstrated meaningful potential in this fight by effectively inactivating the Deformed Wing Virus, offering a promising tool to help protect honeybee populations.” This scientific validation comes at a critical time. Commercial beekeepers across the U.S. have reported colony losses of up to 60% in early 2025 alone, representing an estimated $600 million in economic impact. DWV, largely spread by miticide-resistant Varroa destructor mites, has emerged as the leading cause of these collapses. On June 2, 2025, the USDA confirmed that viruses spread by these mites are the primary cause of the crisis. Honeybees are essential pollinators, contributing $20–30 billion annually to the U.S. agricultural economy and $387 billion globally. The USDA and industry stakeholders continue to search for scalable, effective tools to mitigate this crisis. With SteraMist, TOMI is now positioned to play a key role in protecting global food security through environmental biosecurity. "The economic and ecological impact of honeybee colony collapse cannot be overstated," said Dr. Halden Shane, CEO of TOMI Environmental Solutions. "We are immensely proud that SteraMist offers a proven, effective, and nontoxic solution to provide beekeepers with a powerful disinfection to safeguard their colonies and, by extension, our global food supply. We continue to advance our research and extend our outreach to master beekeepers.” For additional information, please visit http://www.steramist.com or contact us at info@tomimist.com Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995 This press release contains forward-looking statements that are based on current expectations, estimates, forecasts and projections of future performance based on management’s judgment, beliefs, current trends, and anticipated product performance. These forward-looking statements include, without limitation, statements relating to TOMI’s products to serve agriculture sectors. Forward-looking statements involve risks and uncertainties that may cause actual results to differ materially from those contained in the forward-looking statements. These factors include, but are not limited to, our ability to maintain and manage growth and generate sales, our reliance on a single or a few products for a majority of revenues; the general business and economic conditions; and other risks as described in our SEC filings, including our Annual Report on Form 10-K for the fiscal year ended December 31, 2024 filed by us with the SEC and other periodic reports we filed with the SEC. The information provided in this document is based upon the facts and circumstances known at this time. Other unknown or unpredictable factors or underlying assumptions subsequently proving to be incorrect could cause actual results to differ materially from those in the forward-looking statements. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, level of activity, performance, or achievements. You should not place undue reliance on these forward-looking statements. All information provided in this press release is as of today’s date, unless otherwise stated, and we undertake no duty to update such information, except as required under applicable law. INVESTOR RELATIONS CONTACT:John Nesbett/Rosalyn ChristianIMS Investor Relationstomi@imsinvestorrelations.com

Related News